home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

An Interactive Workshop on Premarket [510(k)] Notification Submissions

 
  October 16, 2012  
     
 
ComplianceOnline, Grand Hyatt San Francisco 345 Stockton Street, San Francisco, CA 94108
2012-11-01


Course Description:

At this workshop, Dr. David Lim will walk you through to get familiar with the following subject areas.

510(k) Format and Contents

This workshop is intended to provide guidance on how to format 510(k) submissions including necessary contents to proactively facilitate the FDA review process for medical devices including in vitro diagnosticdevices.

Why Should You Attend:

Understanding regulatory requirements and submission quality of 510(k)s adequately addressing regulatory requirements will greatly facilitate the regulatory review process, leading to fast marketing clearance and saving millions of dollars to organizations!

At this workshop, you will get familiar with 510(k) submissions concerning medical devices including in vitrodiagnostic medical devices.

The following key areas will be discussed during workshop:

  • Federal Statutes and Regulations Governing Medical Devices in the US
  • 510(k) Format and Contents for Various Device Types Including In Vitro Diagnostic Devices

Event Details:

Date:                     November 1st,  2012
Time:                    09:00 AM-04:00 PM PDT
Cost:                    $999 : Seminar One Registration
                  Group Registrations :Call Toll Free +1-888-717-2436
Registration:      SIgn-Up on-line now.  Add to your shopping cart.

 

 
 
Organized by: ComplianceOnline
Invited Speakers:

Instructor:

Dr. David Lim
Ph.D., RAC, ASQ-CAQ

Dr. David Lim obtained his Ph.D. in biological sciences at the University of Missouri-Columbia and published his thesis research in the prestigious journal “Science.” Since then, Dr. Lim has held various positions at Duke, US National Laboratories, Intrexon Corporation, Terumo, US FDA/CDRH, and EraGen Biosciences, Inc., A Luminex Company. In 2009, Dr. Lim served as a panel member during the FDA’s Transparency Public Meeting. Prior to founding his own consulting firm (www.RegulatoryDoctor.com/davidlim), Dr. Lim was Senior Vice President of Scientific and Regulatory Affairs at Aquavit Pharmaceuticals, Inc. 

 
Deadline for Abstracts: 2012-10-30
 
Registration: http://www.complianceonline.com/ecommerce/control/seminar?product_id=80051SEM&?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.